Introduction
Maintaining a steady supply of mature blood cells is essential for defense against infection, tumor surveillance, and maintenance of homeostasis. Normal hematopoiesis can be perturbed by DNA damaging agents such as γ-radiation and chemotherapy drugs. Morbidity rates associated with cancer chemotherapy and radiotherapy limit the effectiveness of these treatments. Radiation and anticancer drugs cause apoptosis in both HSCs and HPCs, leading to severe anemia, bleeding, and infections 1, 2 .
Bone marrow (BM) injury and gastrointestinal toxicity are the two most common limiting factors for cancer therapies of anticancer DNA-damaging agents, such as ionizing radiation and chemotherapeutical drugs. It was established that γ-irradiation (7 Gy to 14 Gy) primarily causes damage to HSCs and HPCs in the BM. As a result, mice have severe BM failure and die between 20 to 30 days after radiation 3 . In contrast, a radiation dose greater than 14 Gy in C57B6 wild-type mice caused lethality due to damage to the small intestine and gastrointestinal (GI) syndrome in addition to BM failure 3 . The damage is not limited to radiation; some chemotherapeutic drugs may also have similar detrimental effects. Therefore, approaches for improving the safety of anticancer DNA-damaging agents must include measures to either increase tumor sensitivity, or reduce toxicity to critical stem cells or progenitors, or both. The latter requires a careful analysis of DNA damage signaling pathways in HSCs.
Mammalian cells evolved a network of interacting pathways that comprise the DNA damage response, leading to (i) cell-cycle arrest, (ii) DNA damage repair, (iii) senescence, or (iv) apoptosis depending on the cell type and extent of DNA damage. The specific conserved genes that participate in the DNA damage response are still being defined. In addition, the detailed pathways governing DNA damage response and outcomes, especially those within HSCs, are not completely understood.
Therefore, efforts to enhance the effectiveness of intensive γ-radiation and chemotherapeutic cancer therapies have been limited. In vivo studies showed that inactivation of p53 increased radioresistance
For personal use only. on July 15, 2017 . by guest www.bloodjournal.org From in HSCs and HPCs, thereby protecting mice against a lethal dose of radiation 4, 5 . It is thought that p53-mediated apoptosis is executed by several of proapoptotic target genes 6 ; however, molecular mechanisms of the DNA damage response in HSCs and HPCs remain elusive.
We previously showed that a highly conserved antiapoptotic transcription factor, Slug, promoted the survival of HPCs by down-modulating radiation-induced upregulation of Puma, thereby conferring radioresistance against 6.5 Gy total body irradiation (TBI), which is a sublethal dose of radiation for wild-type mice. Puma encodes a p53-responsive BH3-only proapoptotic factor. Deletion of Puma converted the radiosensitivity of the Slug-deficient mice to radioresistance to 6.5 Gy TBI 7 . These results implicate a key role of Puma in radiation-induced apoptosis in these critical cells that are responsible for radioresistance. This finding prompted us to explore whether the deletion of Puma alone is sufficient to allow mice to withstand a higher or lethal dose of ionizing radiation by protecting HSCs and HPCs. Studies of the apoptotic pathways and molecules that selectively act in HSCs and HPCs will facilitate the possibility of finding small molecules that improve the therapeutic index of cancer radiotherapy or chemotherapy, or both.
In the present study, we demonstrate that the deletion of Puma allows mice to withstand lethal dose radiation in a hematopoietic cell-autonomous manner, and loss of one Puma allele renders mice radioresistance to 9 Gy TBI. Remarkably, deletion of Puma selectively protects primitive but not differentiated hematopoietic cells from lethal dose radiation, thereby accelerating hematopoietic regeneration. Consistently, Puma deficiency suppresses radiation-induced apoptosis in HSCs and 
Materials and methods

Animal studies
All animal studies were evaluated and approved by the Institutional Animal Care and Use Committee of Maine Medical center. PUMA −/− mice were generated and used after 5 backcrosses to C57BL/6N mice.
p53
−/− mice were purchased from The Jackson Laboratory (Bar Harbor, ME Fernando, CA). The irradiated mice were inspected daily for up to 40 days for radiation-induced death.
Bone marrow histology
Puma
+/+
, Puma
, and Puma −/− mice (8 weeks old) were nonirradiated or γ-irradiated (9 Gy), and then sacrificed at 10 days after irradiation. Femurs were collected and fixed in Bouin's fixative (Labchem INC, Pittsburgh, PA) for an additional 8 days. Sections were made and stained with hematoxylin and eosin.
Bone marrow transplantation
For bone marrow transplantation experiments, mice (4 to 8 weeks old) were fed with acidified antibiotic water and then lethally irradiated with 9 Gy TBI or a total of 13 Gy, given in two fractions of 6.5 Gy 3 hours apart. BM cells were injected into the retroorbital venous sinus of irradiated recipients after depletion of red blood cells.
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From cDNA synthesis and real-time quantitative RT-PCR RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. The cDNA was synthesized by a standard reverse transcription reaction with an oligo-dT primer. Real-time PCR was performed on a Bio-Rad system using SYBR Green-based assays with AmpliTaq Gold (Applied Biosystems, Foster City, CA). The Puma transcripts were analyzed by QPCR, as previously described 7 . The gene expression values were normalized to the geometric mean of the expression values of the housekeeping gene Hprt to obtain relative expression levels. All reactions were performed in triplicate.
Western blot analysis of protein expression level
BMCs were harvested from Puma +/+ and Puma +/− mice at 0, 1.5, and 3 hours after irradiation (5 Gy) and lysed in SDS extraction buffer (6% SDS, 4% β -actin was detected as a loading control.
Flow cytometric analysis of different lineages and apoptotic cells
The mice were sacrificed at the indicated time points after TBI, and the BM cells were flushed from the femurs with PBS containing 2% FBS, filtered through a nylon mesh, and the red blood cells were 
Results
Radiosensitivity is determined by Puma gene dosage
Numerous studies implicate p53 as a pivotal factor that regulate apoptosis in hematopoietic cells exposed to DNA-damaging drugs or γ-radiation 6 . p53 targets include a growing list of proapoptotic genes, including BAX, BAK, Puma, and NOXA 6 . HSCs and HPCs are the most critical cells for survival of mammalian organisms after exposure to DNA-damaging agents 9 ; however, it remains to be determined whether one or a combination of p53 targets mediate apoptosis in these key cells after a high dose of radiation. Our previous study indicated that Slug radioprotects HPCs through direct To test the effects of Puma on the bone marrow failure and death of all wild-type mice (LD100) after exposure to a lethal dose of irradiation, we lethally irradiated Puma
, and Puma −/− mice with 9
Gy TBI. As expected, all of the wild-type mice died within 20 days. Remarkably, deletion of Puma allowed 90% of the irradiated mice to survive more than 35 days after γ-irradiation ( Figure 1A ). Thus, mice lacking Puma survive an otherwise lethal dose of γ-irradiation, even though the mice are wild-type for p53 and Slug.
We also found that 70% of Puma +/− mice (with one Puma copy) withstood 9 Gy TBI ( Figure 1A ).
When the radiation dose was increased from 9 Gy to 9.5 Gy, 20% of Puma +/− mice survived for more than 40 days after γ-irradiation ( Figure 1B ). In comparison to Puma +/− mice, the deletion of Puma 
Radioresistance conferred by Puma deficiency is intrinsic to the transplanted bone marrow cells
To investigate whether Puma deficiency confers resistance to lethal doses of radiation in a hematopoietic cell-autonomous manner, we reconstituted two groups of lethally γ-irradiated wild-type mice with Puma +/+ or Puma −/− BM cells as donor cells using our previously published approach 7 . Thus, these reconstituted mice had the same microenvironment of bone marrow, but had a different hematopoietic compartment ( Figure 1C ). As expected, these mice had an equivalent level of WBC counts (data not shown). Following a second course of 9 Gy TBI given at 2 months after reconstitution, Figure 1D ). By contrast, 90% of the chimeric mice reconstituted with Puma −/− BM cells survived more than 30 days after γ-irradiation ( Figure 1D ). These results demonstrate that Puma deficiency confers radioresistance to lethal dose of radiation in a transplanted hematopoietic cell-autonomous manner, and the effect is not dependent on the bone marrow microenvironment.
Puma deficiency selectively protects HSCs and HPCs against lethal dose radiation
HPCs and HSCs have predominant roles in radioprotection, and they are required for short-term and long-term radioprotection, respectively 9 . We and others showed that Puma has an important role in apoptosis in myeloid progenitor cells 7 and lymphocytes [11] [12] [13] after exposure to a sublethal dose of irradiation. In addition, Puma deficiency also afforded radioresistance to intestinal progenitor cells 14 .
Therefore, we decided to determine whether or not the radioresistance of Puma (Figure 2A -D) .
Interestingly, the total number of myeloid cells is nearly equal in irradiated mice, regardless of Puma genotype ( Figure 2E ). The behavior of T and B cells after 5 Gy TBI is in agreement with the previous report 12 .
Next, we irradiated mice with a high dose of TBI (9 Gy), a lethal dose of irradiation for wild-type mice. The number of surviving LSKs ( Figure 2A ) and HPCs ( Figure 2B ) in the femurs of Puma −/− mice was at least 36-fold and 6-fold higher, respectively, than in Puma +/+ counterparts who received 9 Gy TBI. Surprisingly, we found that the number of surviving T and B lymphocytes and myeloid cells in Together, these results demonstrated that the deletion of Puma selectively protected HSCs (LSKs)
and HPCs in mice exposed to lethal dose of TBI (9 Gy) but not to sublethal dose of TBI (5 Gy). Notably, loss of one Puma allele (Puma +/− ) was sufficient to partially protect LSKs against 9 Gy TBI ( Figure 2A) and HPCs from 5 Gy TBI ( Figure 2B ), which may explain why Puma +/− mice were partially resistant to radiation ( Figure 1A and B). In addition, heterozygosity of Puma radioprotected T and B cells against a sublethal dose but not a lethal dose of TBI ( Figure 2C and D Figure 3A, B) . Similarly, the total number of short-term (ST) HSCs (Flk high LSK cells) was nearly the same in nonirradiated mice, but was 2.5 times higher in Puma −/− mice than in Puma +/+ mice ( Figure 3C ). In contrast, these animals had similar between 40% to 55% in peripheral blood of these reconstituted mice, but increased to 85% at 2 months after a second course of 9 Gy TBI. This data further support the notion that Puma deficiency protects
HSCs against γ-irradiation.
Furthermore, we directly examined the regeneration of hematopoiesis in the BM sections from lethally irradiated Puma
, and Puma −/− mice. As expected, there was no noticeable difference in normal hematopoiesis, regardless of genotypes ( Figure 4C, upper panel) . However, at day 10 after 9
Gy TBI, there were few organized hematopoietic cell clusters in Puma +/+ mice, but significantly more hematopoietic cell clusters evident in the Puma −/− mice ( Figure 4C, lower panel) Figure 1 -4) . We harvested BM cells from irradiated and nonirradiated mice and cultured them in the StemSpan SFEM medium (10 ng/ml IL3 for suppressing spontaneous apoptosis). We analyzed LSK (Lin 
Puma is selectively upregulated in primitive hematopoietic cells and its induction by radiation is in impaired in Puma-heterozygous hematopoietic cells
Our results indicated that deletion of one Puma allele is sufficient to protect animals and their LSKs and HPCs from lethality caused by both sublethal and lethal dose TBI (Figures 1 and 2 ). In addition, Puma
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From expression is known to be upregulated by γ-irradiation in a p53-dependent manner 7, 11 . Thus, we investigated whether loss of one Puma allele resulted in impairment of Puma induction by p53 after γ-irradiation. In agreement with the previous reports 7, 11 , Puma was indeed induced by γ-irradiation in Puma +/+ hematopoietic cells, and its expression increased up to 2-fold at 1.5 hours and 5-fold at 3 hours after γ-irradiation ( Figure 6A ). In contrast, Puma expression in Puma +/− hematopoietic cells only increased up to 1.5-fold at 1.5 hours and 3.5-fold at 3 hours after γ-irradiation ( Figure 6A ). Puma mRNA level in Puma +/− hematopoietic cells was 1. 
differentiated cells. Our data indicate that
Puma is selectively expressed in primitive hematopoietic cells vs. differentiated cells.
Discussion
For personal use only. on July 15, 2017. by guest www.bloodjournal.org From Maintaining the integrity of hematopoiesis is essential for survival of mammalian organisms during lethal intrinsic and extrinsic insults. To accomplish this function, the hematopoietic system replenishes mature blood cells daily and maintains sufficient numbers of stem and progenitor cells to regenerate the hematopoietic system quickly. Therefore, apoptotic pathway(s) should operate differently in mature cells and in primitive hematopoietic cells when exposed uniformly to the same genotoxic agent.
Although p53-deficient mice survive a lethal radiation dose due to increased resistance of HSCs and HPCs in BM 4, 5 , it remains to be determined whether or not a common key factor downstream of p53 mediates radiation-induced apoptosis in these key cells 6 .
Our results indicate that deletion of Puma protects mice from lethal doses of irradiation in a cellautonomous manner. Interestingly, deletion of one Puma allele (Puma
) rendered the mice resistant to 9 Gy TBI, but radioresistance declined when the γ-irradiation dose increased to 9. Puma is primarily induced in primitive cells, and thus is a rate-limiting factor for lethal dose radiationinduced apoptosis in these cells. Indeed, our QPCR data indicated that Puma is selectively expressed in primitive vs. differentiated hematopoietic cells before and after irradiation. The molecular mechanisms underlying lineage-specific Puma transcription regulation should be extensively studied in the future.
The role of Puma in determining the fate of HSCs and HPCs is relevant to cancer therapy because therapeutic doses of radiation and chemotherapy are primarily limited by the sensitivity of these key cells to genotoxic agents. Interestingly, a small molecule inhibitor of p53, which was recently identified by high throughput screening, protects mice from γ-irradiation. There are some safety concerns with this approach due to the critical roles of p53 in tumor suppression and DNA damage repair 27 .
It has been widely assumed that the inability of p53 to induce apoptosis would enable irradiated cells to propagate any chromosomal aberrations sustained from gamma-irradiation exposure, thereby increasing the likelihood of generating new malignant cells. However, recent work from Christophorou et al. 28 and Efgyan et al. 31 surprisingly showed that in mouse models, the inability of p53 to induce apoptosis did not increase the onset of tumor formation, and also that oncogenes rather than p53-mediated apoptosis, provided the key signal to p53 to suppress tumorigenesis.
Consistent with previous reports from others 11, [29] [30] [31] , Puma +/+ mice was similar before irradiation, but is significantly higher in 
